PT88224A - Processo para a preparacao de derivados fenil-tiadiazinona, oxadiazinona e triazinona - Google Patents

Processo para a preparacao de derivados fenil-tiadiazinona, oxadiazinona e triazinona

Info

Publication number
PT88224A
PT88224A PT88224A PT8822488A PT88224A PT 88224 A PT88224 A PT 88224A PT 88224 A PT88224 A PT 88224A PT 8822488 A PT8822488 A PT 8822488A PT 88224 A PT88224 A PT 88224A
Authority
PT
Portugal
Prior art keywords
tiadiazinone
oxadiazinone
phenyl
preparation
triazinone derivatives
Prior art date
Application number
PT88224A
Other languages
English (en)
Other versions
PT88224B (pt
Inventor
Michel Martin
Guy Nadler
Richard Zimmermann
Original Assignee
Sobio Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB878718957A external-priority patent/GB8718957D0/en
Priority claimed from GB888811276A external-priority patent/GB8811276D0/en
Application filed by Sobio Lab filed Critical Sobio Lab
Publication of PT88224A publication Critical patent/PT88224A/pt
Publication of PT88224B publication Critical patent/PT88224B/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20Oxygen atoms
    • C07D215/22Oxygen atoms attached in position 2 or 4
    • C07D215/227Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32Oxygen atoms
    • C07D209/34Oxygen atoms in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56Ring systems containing three or more rings
    • C07D209/96Spiro-condensed ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/10Spiro-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
PT88224A 1987-08-11 1988-08-09 Processo para a preparacao de derivados fenil-tiadiazinona, oxadiazinona e triazinona PT88224B (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB878718957A GB8718957D0 (en) 1987-08-11 1987-08-11 Compounds
GB888811276A GB8811276D0 (en) 1988-05-12 1988-05-12 Compounds

Publications (2)

Publication Number Publication Date
PT88224A true PT88224A (pt) 1989-06-30
PT88224B PT88224B (pt) 1995-03-01

Family

ID=26292594

Family Applications (1)

Application Number Title Priority Date Filing Date
PT88224A PT88224B (pt) 1987-08-11 1988-08-09 Processo para a preparacao de derivados fenil-tiadiazinona, oxadiazinona e triazinona

Country Status (7)

Country Link
US (1) US4933336A (pt)
EP (1) EP0303418A3 (pt)
JP (1) JPH01110681A (pt)
KR (1) KR890003751A (pt)
AU (1) AU2056688A (pt)
DK (1) DK445288A (pt)
PT (1) PT88224B (pt)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU614965B2 (en) * 1987-06-06 1991-09-19 Merck Patent Gesellschaft Mit Beschrankter Haftung Thiadiazinones
GB8816944D0 (en) * 1988-07-15 1988-08-17 Sobio Lab Compounds
GB8901836D0 (en) * 1989-01-27 1989-03-15 Sobio Lab Compounds
DE3913597A1 (de) * 1989-04-25 1990-11-08 Heumann Pharma Gmbh & Co Diazinderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
US4952703A (en) * 1989-05-25 1990-08-28 Pfizer Inc. Intermediates for making 2-oxindole-1-carboxamides
DE4041074A1 (de) * 1990-12-21 1992-06-25 Merck Patent Gmbh Thiadiazinonderivate
FR2686878B1 (fr) * 1992-01-30 1995-06-30 Sanofi Elf Derives du n-sulfonyl oxo-2 indole, leur preparation, les compositions pharmaceutiques en contenant.
US5502072A (en) * 1993-11-26 1996-03-26 Pfizer Inc. Substituted oxindoles
AU6030098A (en) * 1997-01-16 1998-08-07 Neorx Corporation Phalloidin derivatives and analogs to treat congestive heart failure
US6268512B1 (en) 1998-01-16 2001-07-31 Medical Information Services, Inc. Process for producing 3-methyl-2-oxoindoline
US6358948B1 (en) 1999-05-04 2002-03-19 American Home Products Corporation Quinazolinone and benzoxazine derivatives as progesterone receptor modulators
US6417214B1 (en) * 1999-05-04 2002-07-09 Wyeth 3,3-substituted indoline derivatives
US6391907B1 (en) * 1999-05-04 2002-05-21 American Home Products Corporation Indoline derivatives
US6407101B1 (en) 1999-05-04 2002-06-18 American Home Products Corporation Cyanopyrroles
US6509334B1 (en) * 1999-05-04 2003-01-21 American Home Products Corporation Cyclocarbamate derivatives as progesterone receptor modulators
US6355648B1 (en) 1999-05-04 2002-03-12 American Home Products Corporation Thio-oxindole derivatives
CZ2002711A3 (cs) 1999-08-27 2003-11-12 Ligand Pharmaceuticals Incorporated Modulátory androgenních receptorů, způsoby jejich výroby a způsoby jejich použití
US6566372B1 (en) 1999-08-27 2003-05-20 Ligand Pharmaceuticals Incorporated Bicyclic androgen and progesterone receptor modulator compounds and methods
AU6941200A (en) 1999-08-27 2001-03-26 Ligand Pharmaceuticals Incorporated 8-substituted-6-trifluoromethyl-9-pyrido(3,2-g)quinoline compounds as androgen receptor modulators
WO2001019770A2 (en) 1999-09-14 2001-03-22 Ligand Pharmaceuticals Incorporated Rxr modulators with improved pharmacologic profile
US6696473B2 (en) * 2001-12-21 2004-02-24 X-Ceptor Therapeutics, Inc. Heterocyclic modulators of nuclear receptors
EP1656142A4 (en) * 2003-08-22 2011-06-22 Ligand Pharm Inc 6-CYCLOAMINO-2-QUINOLINONE DERIVATIVES AS MODULATORS ANDROGEN RECEPTOR COMPOUNDS
CN107235992B (zh) * 2017-07-06 2019-08-20 中国人民解放军第四军医大学 吲哚酮螺四氢噻吩类化合物及其盐、制备方法和应用
JOP20200024A1 (ar) 2017-08-04 2020-02-02 Bayer Ag مركبات ثنائي هيدروكساديازينون
EP3661917B1 (en) 2017-08-04 2022-05-11 Bayer Aktiengesellschaft 6-((3-trifluoromethyl)phenyl)-4,5-dihydropyridazin-3(2h)-one derivatives as pde3a and pde3b inhibitors for treating cancer
US20240308973A1 (en) * 2023-03-10 2024-09-19 Zoetis Services Llc Phosphodiesterase 3 (pde3) inhibitors

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4581356A (en) * 1983-03-22 1986-04-08 Fujisawa Pharmaceutical Co., Ltd. Triazine derivatives, and pharmaceutical compositions comprising the same
JPS61106574A (ja) * 1984-10-29 1986-05-24 Yoshitomi Pharmaceut Ind Ltd オキサ(またはチア)ジアジン誘導体
DE3623532A1 (de) * 1986-07-12 1988-01-21 Bayer Ag Verwendung von thiadiazinonen zur bekaempfung von endoparasiten

Also Published As

Publication number Publication date
KR890003751A (ko) 1989-04-17
PT88224B (pt) 1995-03-01
DK445288D0 (da) 1988-08-09
US4933336A (en) 1990-06-12
DK445288A (da) 1989-02-12
EP0303418A3 (en) 1990-11-07
AU2056688A (en) 1989-02-16
JPH01110681A (ja) 1989-04-27
EP0303418A2 (en) 1989-02-15

Similar Documents

Publication Publication Date Title
PT88224A (pt) Processo para a preparacao de derivados fenil-tiadiazinona, oxadiazinona e triazinona
BR8803759A (pt) Processo para a preparacao de 2,2,6,6-tetrametil-4-piperidilaminas
PT93785A (pt) Processo para a preparacao de derivados de 3-substituido-2-oxindole
PT94059A (pt) Processo para a preparacao de copolimetros hidrossoluveis, de n-vinilamidas
BR8902297A (pt) Processo para a preparacao de 1,1,1,2-tetrafluoretano
PT89705B (pt) Processo para a preparacao de 2', 3'-didesoxi-2', 2'-difluoronucleosidos
PT87707A (pt) Processo para a preparacao de derivados de 2-anilino-pirimidina
PT84561B (pt) Processo aperfeicoado para a preparacao de derivados macrolidos
BR8804344A (pt) Processo para a preparacao de compostos,compostos obtidos,processo para a preparacao de produtos e aplicacao
BR8802843A (pt) Processo para a preparacao de alcanotriois e alcanopoliois
PT88181A (pt) Processo para a preparacao de derivados aralquilaminoalcoxifenilo
PT93629A (pt) Processo para a preparacao de derivados de tieno-triazolo-diazepina
PT92365A (pt) Processo para a preparacao de (s)-alfa-etil-2-oxo-1-pirrolidinoacetamida
BR8706915A (pt) Processo para a preparacao de derivados metoxibenzofenona,metoxibenzofenonas e composto
PT89775A (pt) Processo para a preparacao de derivados de isoquinolina
PT92539A (pt) Processo para a preparacao de derivados de anfotericina b
PT91027A (pt) Processo para a preparacao de derivados peptidicos
PT84459B (pt) Processo para a preparacao de derivados de ciclopropano 1,1-dissubstituidos
PT93033A (pt) Processo para a preparacao de derivados de guanidina
PT87946A (pt) Processo para a preparacao de derivados 4-amino susbtituido-1,2-dihidroxinaftaleno
PT93631A (pt) Processo para a preparacao de derivados de tieno-triazolo-diazepina
PT88924A (pt) Processo para a preparacao de derivados de ginkgolidos
PT83636B (pt) Processo para a preparacao de 5-aril-2,4-dialquil-3h-1,2,4-triazole-3-tionas
PT90588A (pt) Processo para a preparacao de dibenzotiofenos substituidos
BR8905815A (pt) Processo para preparacao de cetoximossilanos

Legal Events

Date Code Title Description
FG3A Patent granted, date of granting

Effective date: 19940822

MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 19960229